Dr. Mikhail Blagosklonny’s Quest to Fight Cancer and the Effects of Aging

Rapamycin is a drug that may prove to have immense benefits for the human race. It has been used as a coating for coronary stents, for treating a rare lung disease, and as a cancer drug.

It was first isolated from a bacterium called Sirolimus found on Easter Island in 1972, and was first used as an anti-fungal agent. Mikhail Blagosklonny, a professor of Oncology at Rosewell Park Cancer Institute in Buffalo, New York, believes it can do much more. He has done monumental research on cancer and its therapies, as well as on aging. As the Editor-in-Chief of Oncotarget, a journal that publishes research papers on cancer and oncology, he has been an advocate for the use of Rapamycin for the purposes of increasing the human lifespan.

Research into the properties of Rapamycin proves its immense benefits. Here are a few of the ways it has been used:

  • Its immunosuppressant properties aid the body in accepting organ transplants. It is much less damaging to the kidneys than other anti-rejection drugs.
  • It is the primary drug used to treat Lymphangioleiomyomatosis (LAM), a rare lung disease that usually affects women of childbearing age.
  • Its use as a coronary stent coating prevents the occurrence of restenosis, or narrowing of the arteries, following balloon angioplasty.
  • Rapamycin has antiproliferative properties that help in the treatment of cancer. It can enhance the immune response and promotes tumor regression. In addition, it can reduce the risk to cancer patients when undergoing organ transplants.

While results are not conclusive yet, Dr. Mikhail Blagosklonny’s research into the anti-aging benefits of this drug is promising and certainly exciting. Tests have been done on mice and are currently being done on marmoset monkeys, as well as some initial tests on humans.

Other possible uses for Rapamycin include the treatment of Alzheimer’s, Muscular Dystrophy and Systemic Lupus Erythematosus. Research continues to show the many ways this medicine may benefit the human race, and initial results are encouraging. Dr. Mikhail Blagosklonny has been a pioneer in this research and an advocate for its use in increasing the human lifespan.

Dr. Mikhail Blagosklonny’s work as a researcher strives to find a way to eliminate cancerous cells without destroying the healthy cells in the body. He hopes to find a way to treat cancer effectively without the expense or excruciating side effects present in today’s treatments. He has made much progress in his fields of interest and hopes to inspire others in the future.

As a researcher, a professor, and a philanthropist, Dr. Mikhail Blagosklonny wants to help provide the world with the best treatment possible for cancer without regard to economic standing. He is most interested in medical research and his focus has been on both cancer and anti-aging. He continues to be influential in these fields and an inspiration to his students as well as his peers.

LinkedIn: https://www.linkedin.com/in/mikhail-blagosklonny-91abb531/

Leave a Reply

Your email address will not be published. Required fields are marked *